One of the most prevalent cancers in the world is colorectal carcinoma (CRC).
Aggressive cancer forms and a poor prognosis are linked to cancer stem cell (CSC) markers.
The study aimed to determine whether the co-expression of the CSC markers CD133 and CD44 could predict an increased risk of metastasis in colorectal cancer.
